Items where authors include "David, E."

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 8.

Article

Monderer, D., Luseau, A., Bellec, A. et al. (14 more authors) (2013) New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance. Laboratory Investigation, 93 (10). pp. 1100-1114. ISSN 0023-6837

Miot-Noirault, E., David, E., Vidal, A. et al. (8 more authors) (2013) Tc-99m-NTP 15-5 assessment of the early therapeutic response of chondrosarcoma to zoledronic acid in the Swarm rat orthotopic model. EJNMMI Research, 3. 40. ISSN 2191-219X

David, E., Tirode, F., Baud'huin, M. et al. (7 more authors) (2012) Oncostatin M Is a Growth Factor for Ewing Sarcoma. The American Journal of Pathology, 181 (5). pp. 1782-1795. ISSN 0002-9440

Peyrode, C., Weber, V., David, E. et al. (10 more authors) (2012) Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studies. Investigational New Drugs, 30 (4). pp. 1782-1790. ISSN 0167-6997

Guihard, P., Danger, Y., Brounais, B. et al. (9 more authors) (2012) Induction of Osteogenesis in Mesenchymal Stem Cells by Activated Monocytes/Macrophages Depends on Oncostatin M Signaling. Stem Cells, 30 (4). pp. 762-772. ISSN 1066-5099

David, E., Guihard, P., Brounais, B. et al. (10 more authors) (2011) Direct anti-cancer effect of oncostatin M on chondrosarcoma. International Journal of Cancer, 128 (8). pp. 1822-1835. ISSN 0020-7136

David, E., Blanchard, F., Heymann, M.F. et al. (4 more authors) (2011) The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets. Sarcoma, 2011. 932451. ISSN 1357-714X

Brounais, B., David, E., Chipoy, C. et al. (8 more authors) (2009) Long term oncostatin M treatment induces an osteocyte-like differentiation on osteosarcoma and calvaria cells. Bone, 44 (5). pp. 830-839. ISSN 8756-3282

This list was generated on Sat Mar 23 13:03:22 2024 GMT.